Laurence Ainouz



Laurence Ainouz

CEO, Health:Augmented

Laurence Ainouz is the former Novartis VP Global Head of the Digital Acceleration Labs, a unit she built in Switzerland, San Francisco, New York and Tel Aviv with the purpose of generating innovative technological solutions to profoundly transform the patient’s journey and experience, to maximize treatments’ outcomes and push the digital agenda, collaboration with startups & strategic partnerships in the organization. 
Previously, Laurence was SVP Chief Innovation Officer of Teva, the world’s largest provider of generic medicines, responsible for introducing all aspects of Digital Health to the organization, from new technologies to new business models. Before her Healthcare journey, Laurence co-founded a telecom startup in Paris in 1998 which was acquired in 2006. 

In addition to her pharma work, Laurence sits on the board of the non-profit United Hatzalah, a unique global organization that has disrupted  the way Emergency Medical Services are provided. In 2017, 4,000 geo-localized volunteers and a fleet of “ambucycles” (2 wheels ambulances) brought critical medical care in less than 3 minutes to more than 280,000 people, over 60,000 of whom were in life-or-death situations. United Hatzalah has also a search unit, and a PTSD prevention unit. The organization is deployed in the USA, the UK, in Panama, Ukraine, France (Laurence is also the President of the French Entity). 

Laurence also sits on the board of TOM, a global network of 3,000 makers deeply impacting the lives of thousands of disabled people with makethons where people with disabilities and “Makers” develop solutions together. TOM is supported by Google, and has run all over the world. TOM has launched the first global makerspace completely dedicated to assistive technologies at the heart of the innovation ecosystem of Tel Aviv. Laurence also sits on the board of the mother organization, the prestigious think tank Reut Institute.

Laurence is currently running Health:Augmented a boutique consulting firm helping big pharma to deploy innovation capabilities and processes, and to locate, evaluate, interact and invest in relevant start-ups.







until tickets increase Buy now!